An update on thalassemia intermedia
The Spine in β-thalassemia syndromes
Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
Effects of divalproex sodium on hemoglobin level
Clinicovirologic analysis of hepatitis C infection in transfusion-dependent β-thalassemia major children
Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: Uncovering yet another covert abnormality
Primary pure squamous cell carcinoma of the breast: A case report and review of the literature
Optimal management of β thalassaemia intermedia
Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia
Age-related complications in treatment-naïve patients with thalassaemia intermedia
Budd-Chiari syndrome with underlying homozygous factor V Leiden and heterozygous methylenetetrahydrofolate reductase mutations [4]
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia
A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia
Carbamazepine-induced thrombocytopenia
Thromboembolism and toxic shock syndrome: A case presentation and literature update
Efficacy and safety of deferasirox at low and high iron burdens: Results from the EPIC magnetic resonance imaging substudy
Iron and hepatitis C: What can we learn from thalassemia major?
Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: A single institution experience from the American University of Beirut